{
    "N/R/U": null,
    "Applicant": "Rare Disease Therapeutics, Inc. (RDT)",
    "BLA Number": "125488",
    "Proprietary Name": "Anavip",
    "Proper Name": "Crotalidae Immune F(ab')2 (Equine)",
    "BLA Type": "351(a)",
    "Strength": "MINIMUM 780 BOTHROPS ASPER, 790 C.SIMUS, 244 C.ADAMANTEUS, 147 C.ATROX, 185 C.SCUTULATUS, 28 AGKISTRODON CONTORTRIX, 61 A.PISCIVORUS LD50 NEUTRALIZING UNITS/VIAL",
    "Dosage Form": "For Injection",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Single-Dose Vial",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "6-May-15",
    "Ref. Product Proper Name": " ",
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "1860",
    "Product Number": "1",
    "Center": "CBER",
    "Date of First Licensure": null,
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": null,
    "Orphan Exclusivity Exp. Date": "6-May-22",
    "drug": [
        {
            "name": "Crotalidae Immune F(ab')2 (Equine)"
        }
    ]
}